Venus Medtech Stock Price Patterns
| VMTHF Stock | USD 0.27 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Venus Medtech hype-based prediction, you can estimate the value of Venus Medtech from the perspective of Venus Medtech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Venus Medtech to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Venus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Venus Medtech after-hype prediction price | USD 0.27 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Venus |
Venus Medtech After-Hype Price Density Analysis
As far as predicting the price of Venus Medtech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Venus Medtech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Venus Medtech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Venus Medtech Estimiated After-Hype Price Volatility
In the context of predicting Venus Medtech's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Venus Medtech's historical news coverage. Venus Medtech's after-hype downside and upside margins for the prediction period are 0.01 and 1.59, respectively. We have considered Venus Medtech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Venus Medtech is extremely dangerous at this time. Analysis and calculation of next after-hype price of Venus Medtech is based on 3 months time horizon.
Venus Medtech Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Venus Medtech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Venus Medtech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Venus Medtech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 1.32 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.27 | 0.27 | 0.00 |
|
Venus Medtech Hype Timeline
Venus Medtech is at this time traded for 0.27. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Venus is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.21%. %. The volatility of related hype on Venus Medtech is about 132000.0%, with the expected price after the next announcement by competition of 0.27. About 22.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.08. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Venus Medtech recorded a loss per share of 0.13. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be any time. Check out Venus Medtech Basic Forecasting Models to cross-verify your projections.Venus Medtech Related Hype Analysis
Having access to credible news sources related to Venus Medtech's direct competition is more important than ever and may enhance your ability to predict Venus Medtech's future price movements. Getting to know how Venus Medtech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Venus Medtech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MDXHF | MedX Health Corp | 0.00 | 0 per month | 0.00 | 0.10 | 0.00 | 0.00 | 202.73 | |
| RCEL | Avita Medical | (0.01) | 14 per month | 2.56 | 0.01 | 6.67 | (4.23) | 17.83 | |
| BCCOY | BICO Group AB | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 23.62 | |
| CLLKF | Cellink AB | 0.00 | 0 per month | 0.00 | (0.10) | 0.00 | (8.14) | 28.09 | |
| DMTRF | 3 D Matrix | 0.00 | 0 per month | 0.00 | 0.16 | 0.00 | 0.00 | 27.33 | |
| PXMBF | Paxman AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IMPZY | Implanet SA ADR | 0.00 | 0 per month | 0.00 | (1.34) | 0.00 | 0.00 | 0.25 | |
| JUSHF | Jushi Holdings | 0.00 | 0 per month | 9.50 | 0.03 | 18.33 | (10.77) | 104.05 | |
| MLLCF | Molecular Partners AG | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | (3.61) | 48.13 | |
| SPHDF | Santhera Pharmaceuticals Holding | 0.00 | 0 per month | 0.00 | (0.02) | 0.00 | 0.00 | 8.71 |
Venus Medtech Additional Predictive Modules
Most predictive techniques to examine Venus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Venus using various technical indicators. When you analyze Venus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Venus Medtech Predictive Indicators
The successful prediction of Venus Medtech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Venus Medtech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Venus Medtech based on analysis of Venus Medtech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Venus Medtech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Venus Medtech's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for Venus Pink Sheet analysis
When running Venus Medtech's price analysis, check to measure Venus Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Venus Medtech is operating at the current time. Most of Venus Medtech's value examination focuses on studying past and present price action to predict the probability of Venus Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Venus Medtech's price. Additionally, you may evaluate how the addition of Venus Medtech to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |